Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| RMNI | Hershkowitz Steven | EVP & Chief Revenue Officer | 02.11.2026 | Optionsausübung | 3,48 | 9.149 | 31.839 | Form 4 |
| RAMP | Sharma Vihan | CHIEF REVENUE OFFICER | 02.11.2026 | Abgabe | 38,50 | 294.783 | 11.349.146 | Form 4 |
| RAMP | Howe Scott E | CHIEF EXECUTIVE OFFICER | 02.11.2026 | Abgabe | 38,50 | 3.148 | 121.198 | Form 4 |
| RAMP | Howe Scott E | CHIEF EXECUTIVE OFFICER | 02.11.2026 | Abgabe | 38,50 | 1.624.429 | 62.540.517 | Form 4 |
| RAMP | Karasick Matthew | CHIEF PRODUCT OFFICER | 02.11.2026 | Abgabe | 38,50 | 222.153 | 8.552.891 | Form 4 |
| RAMP | Dillard Lauren R | CHIEF FINANCIAL OFFICER | 02.11.2026 | Abgabe | 38,50 | 560.794 | 21.590.569 | Form 4 |
| RAMP | Jones Jerry C | CHIEF ETHICS & LEGAL OFFICER | 02.11.2026 | Abgabe | 38,50 | 3.495 | 134.558 | Form 4 |
| RAMP | Jones Jerry C | CHIEF ETHICS & LEGAL OFFICER | 02.11.2026 | Abgabe | 38,50 | 5.397 | 207.785 | Form 4 |
| RAMP | Jones Jerry C | CHIEF ETHICS & LEGAL OFFICER | 02.11.2026 | Abgabe | 38,50 | 318.804 | 12.273.954 | Form 4 |
| RAMP | Cadogan Timothy R. | Director | 02.11.2026 | Abgabe | 38,50 | 62.157 | 2.393.045 | Form 4 |
| RAMP | Chow Vivian | Director | 02.11.2026 | Abgabe | 38,50 | 31.263 | 1.203.626 | Form 4 |
| RAMP | Kokich Clark M | Director | 02.11.2026 | Abgabe | 38,50 | 106.609 | 4.104.447 | Form 4 |
| RAMP | Tomlin Debora B | Director | 02.11.2026 | Abgabe | 38,50 | 35.133 | 1.352.621 | Form 4 |
| RAMP | Battelle John L. | Director | 02.11.2026 | Abgabe | 38,50 | 59.476 | 2.289.826 | Form 4 |
| R | Regan Thomas Michael | EVP of DTS | 01.11.2026 | Steuer-Abgabe | 282,55 | 1.968 | 556.058 | Form 4 |
| RNR | Marra David E | EVP,Chief Underwriting Officer | 01.11.2026 | Steuer-Abgabe | 339,32 | 653 | 221.576 | Form 4 |
| RGNX | Malzahn Craig | Chief Technology Officer | 01.11.2026 | Zuteilung | — | 27.777 | — | Form 4 |
| RGNX | Chan Mitchell | Chief Financial Officer | 01.11.2026 | Zuteilung | — | 24.305 | — | Form 4 |
| RGNX | Pakola Steve | Chief Medical Officer | 01.11.2026 | Zuteilung | — | 34.722 | — | Form 4 |
| RGNX | Christmas Patrick J. | Chief Strategy & Legal Officer | 01.11.2026 | Zuteilung | — | 34.722 | — | Form 4 |
| RBBN | McCaffery Stephen J. | EVP, Global Sales | 31.10.2026 | Steuer-Abgabe | 1,55 | 50.762 | 78.681 | Form 4 |
| RBBN | McCaffery Stephen J. | EVP, Global Sales | 31.10.2026 | Optionsausübung | — | 108.006 | — | Form 4 |
| RBBN | McCaffery Stephen J. | EVP, Global Sales | 31.10.2026 | Steuer-Abgabe | 1,55 | 16.921 | 26.228 | Form 4 |
| RBBN | McCaffery Stephen J. | EVP, Global Sales | 31.10.2026 | Optionsausübung | — | 36.003 | — | Form 4 |
| RAPP | Third Rock Ventures V, L.P. | Director | 30.10.2026 | Zuteilung | 21,00 | 1.190.476 | 24.999.996 | Form 4 |
| RAPP | Third Rock Ventures V, L.P. | Director | 30.10.2026 | Zuteilung | 21,00 | 238.095 | 4.999.995 | Form 4 |
| R | Havens Thomas M. | President, FMS | 30.10.2026 | Verkauf | 283,13 | 5.500 | 1.557.215 | Form 4 |
| RTX | Williams Dantaya M | EVP & Chief HR Officer | 30.10.2026 | Verkauf | 201,70 | 9.071 | 1.829.576 | Form 4 |
| RTX | Williams Dantaya M | EVP & Chief HR Officer | 30.10.2026 | Abgabe | 201,62 | 7.929 | 1.598.645 | Form 4 |
| RTX | Williams Dantaya M | EVP & Chief HR Officer | 30.10.2026 | Optionsausübung | 94,04 | 17.000 | 1.598.680 | Form 4 |
| ROP | Stipancich John K | EVP, Chief Legal Officer & Sec | 30.10.2026 | Verkauf | 468,09 | 4.200 | 1.965.978 | Form 4 |
| ROP | Stipancich John K | EVP, Chief Legal Officer & Sec | 30.10.2026 | Optionsausübung | 275,69 | 4.200 | 1.157.898 | Form 4 |
| REGN | Guarini Kathryn | Director | 30.10.2026 | Verkauf | 900,00 | 400 | 360.000 | Form 4 |
| REGN | Guarini Kathryn | Director | 30.10.2026 | Optionsausübung | 719,37 | 400 | 287.748 | Form 4 |
| REGN | McCourt Marion | EVP Commercial | 30.10.2026 | Verkauf | 869,43 | 1.132 | 984.195 | Form 4 |
| REGN | Brown Michael S | Director | 30.10.2026 | Verkauf | 875,00 | 1.929 | 1.687.875 | Form 4 |
| REGN | Brown Michael S | Director | 30.10.2026 | Optionsausübung | 725,89 | 1.929 | 1.400.242 | Form 4 |
| RBBN | McClelland Bruce William | President & CEO | 30.10.2026 | Kauf | 1,60 | 60.000 | 96.240 | Form 4 |
| RLI | Roberts Debbie Sharell | Director | 30.10.2026 | J | 65,23 | 383 | 24.983 | Form 4 |
| RLI | Medini Paul Bennett | Director | 30.10.2026 | J | 65,23 | 479 | 31.245 | Form 4 |
| RVSB | Girod Jon Louis | Director | 30.10.2026 | Kauf | 6,04 | 2.000 | 12.080 | Form 4 |
| RDWR | Tauman Yair | Director | 30.10.2026 | Verkauf | 36,05 | 1.919 | 69.180 | Form 4 |
| RIVN | McDonough Claire | Chief Financial Officer | 30.10.2026 | Abgabe | — | 730.292 | — | Form 4 |
| RCL | Montiel Maritza Gomez | Director | 30.10.2026 | Verkauf | 307,21 | 400 | 122.884 | Form 4 |
| RLYB | Lieber Jonathan I | Chief Financial Officer | 29.10.2026 | Optionsausübung | 6,08 | 13.589 | 82.621 | Form 4 |
| RLYB | Lieber Jonathan I | Chief Financial Officer | 29.10.2026 | Optionsausübung | 14,88 | 7.875 | 117.180 | Form 4 |
| RLYB | Hunt Ronald | Director | 29.10.2026 | Optionsausübung | 15,28 | 2.062 | 31.507 | Form 4 |
| RLYB | Hunt Ronald | Director | 29.10.2026 | Optionsausübung | 7,60 | 9.196 | 69.890 | Form 4 |
| RLYB | Hunt Ronald | Director | 29.10.2026 | Optionsausübung | 2,38 | 3.562 | 8.478 | Form 4 |
| R | Gallo-Aquino Cristina | EVP and CFO | 29.10.2026 | Verkauf | 276,85 | 1.238 | 342.740 | Form 4 |
| R | Gallo-Aquino Cristina | EVP and CFO | 29.10.2026 | Optionsausübung | 74,72 | 1.238 | 92.503 | Form 4 |
| ROL | R. Randall Rollins Voting Trust U/A dated August 25, 1994 | 10% Owner | 29.10.2026 | Kauf | 34,59 | 1.444.402 | 49.956.665 | Form 4 |
| ROL | Lor Inc | 10% Owner | 29.10.2026 | Kauf | 34,59 | 1.444.402 | 49.956.665 | Form 4 |
| RELL | Halverson Kenneth | Director | 29.10.2026 | Verkauf | 21,19 | 1.000 | 21.190 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 29.10.2026 | Verkauf | 38,01 | 810 | 30.788 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 29.10.2026 | Verkauf | 37,47 | 1.310 | 49.086 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 29.10.2026 | Verkauf | 36,14 | 480 | 17.347 | Form 4 |
| RBCAA | Starke Jeff | EVP, CHIEF INFORMATION OFFICER | 29.10.2026 | Verkauf | 92,91 | 3 | 279 | Form 4 |
| RBCAA | Starke Jeff | EVP, CHIEF INFORMATION OFFICER | 29.10.2026 | Verkauf | 92,40 | 817 | 75.491 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 28.10.2026 | Verkauf | 36,59 | 200.000 | 7.318.000 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).